NCT03603366View on ClinicalTrials.gov

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

CompletedOBSERVATIONAL
Enrollment

1,028

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

October 14, 2019

Study Completion Date

October 14, 2019

Conditions
Cardiovascular DiseaseColorectal Cancer
Interventions
DRUG

Acetylsalicylic acid (Aspirin, BAYE4465)

This study does not involve prescription of the drugs. This study is a cross-sectional survey of patients taking low-dose aspirin or patients who are eligible but not taking low-dose aspirin.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY